Lyophilized Injectable Drugs Market
According to Intent Market Research, the Lyophilized Injectable Drugs Market is expected to grow from USD 3.9 Billion in 2024-e at a CAGR of 3.7% to touch USD 4.8 Billion by 2030. The Lyophilized Injectable Drugs Market is dominated by key players such as, Pfizer Inc., Eli Lilly and Co., Roche Holding AG, Merck & Co., Inc., Johnson & Johnson, and Sanofi S.A.